早产儿视网膜病变的靶向血液代谢组学研究
该研究对81例胎龄<34周的早产儿(40例ROP、41例匹配非ROP对照)进行靶向血液代谢组学检测,采用超高效液相色谱-串联质谱分析代谢物。研究发现甘氨酸、谷氨酸、亮氨酸、丝氨酸、哌啶、缬氨酸、色氨酸、瓜氨酸、丙二酰肉碱(C3DC)和同型半胱氨酸为最具判别力的代谢物,其中C3DC和甘氨酸浓度在ROP与非ROP婴儿间差异有统计学意义。作者提示较高血液C3DC和甘氨酸水平可能有助于预测ROP发生而非严重程度。
要点
- C3DC和甘氨酸在ROP与非ROP早产儿间浓度差异有统计学意义。
- 较高C3DC和甘氨酸水平可能预测ROP发生,而非严重程度。
核心结论
- 较高血液C3DC和甘氨酸水平可能作为预测ROP发生的候选生物标志物,但不能预测其严重程度。
研究设计与样本
- 靶向血液代谢组学研究纳入81例胎龄<34周的早产儿,其中ROP组40例、匹配的非ROP对照组41例。
- 采用超高效液相色谱-串联质谱测定代谢物,并进行标准多变量和单变量分析。
主要发现
- 甘氨酸、谷氨酸、亮氨酸、丝氨酸、哌啶、缬氨酸、色氨酸、瓜氨酸、C3DC和同型半胱氨酸被确定为最具判别力的代谢物。
- 单变量分析证实C3DC和甘氨酸的判别浓度在ROP与非ROP婴儿间差异有统计学意义。
临床怎么用
- 血液C3DC和甘氨酸或可作为ROP发生风险的早期预警指标,但不用于判断病变严重程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aims at exploring alterations of major metabolites and metabolic pathways in retinopathy of prematurity (ROP) infants and identifying biomarkers that may merit early diagnosis of ROP. METHODS: We analyzed targeted metabolites from 81 premature infants (<34 weeks of gestational age), including 40 ROP cases (15 males and 25 females, birth weight 1.263 ± 0. 345 kg, gestational age 31.20 ± 4.62 weeks) and 41 cases (30 males, 11 females, birth weight 1.220 ± 0.293 kg, gestational age 30.96 ± 4.17 weeks) of well-matched non-ROP controls. Metabolites were measured by ultra-performance liquid chromatography-tandem mass spectrometry. Standard multivariate and univariate analysis was performed to interpret metabolomic results. RESULTS: Glycine, glutamate, leucine, serine, piperidine, valine, tryptophan, citrulline, malonyl carnitine (C3DC), and homocysteine were identified as the top discriminant metabolites. In particular, discriminant concentrations of C3DC and glycine were also confirmed by univariate analysis as statistically significant different between ROP and non-ROP infants. CONCLUSIONS: This study gained an insight into the metabolomic aspects of ROP development. We suggest that higher blood levels of C3DC and glycine can be promising biomarkers to predict the occurrence, but not the severity of ROP.
引用
- Yang Y, Wu Z, Li S, et al. Targeted Blood Metabolomic Study on Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2020. PMID: 32049343. doi:10.1167/iovs.61.2.12
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。